0
Allergy and Airway |

Recurrent Respiratory Papillomatosis and Squamous Cell Carcinoma of the Lung in an HIV Positive Man

Rishi Mehta, MD; Jean Anderson Eloy, MD; Andrew Berman, MD
Author and Funding Information

UMDNJ-NJMS, Newark, NJ


Chest. 2013;144(4_MeetingAbstracts):45A. doi:10.1378/chest.1702461
Text Size: A A A
Published online

Abstract

SESSION TITLE: Airway Cases II

SESSION TYPE: Medical Student/Resident Case Report

PRESENTED ON: Wednesday, October 30, 2013 at 11:30 AM - 12:30 PM

INTRODUCTION: Recurrent respiratory papillomatosis (RRP) is a rare, benign neoplasm of the airway caused by human papilloma virus (HPV). Adults with RRP are often immunocompromised, and lesions tend to be aggressive. Malignant transformation has been reported to occur. We report a case of RRP in an HIV positive man with upper airway obstruction and recurrent squamous cell carcinoma (SCC) of the lung.

CASE PRESENTATION: A 50 year old male former smoker with AIDS and recurrent sinonasal papillomas comes to the Emergency Department (ED) because of shortness of breath. Medical history includes: Hodgkin’s Lymphoma, treated 5 years ago, and SCC of the lung, resected one year later. Papillomas have been treated since the time of diagnosis 10 years ago, with multiple debulking procedures and interferon. In the ED, patient reported progressive dyspnea over 3 months, a productive cough with white, non-bloody sputum, and a hoarse voice. On examination, inspiratory and expiratory stridor with mildly labored respirations was noted; room air oxygen saturation was 100%. MRI of the neck revealed a large tracheal mass causing near complete obstruction. PFTs were consistent with fixed airway obstruction. The patient was intubated, and underwent surgical debulking, plus treatment with a microdebrider and C02 laser, and intralesional injection of cidofavir. The patient was extubated 1 day post op with significant improvement. Five months later, he was readmitted for recurrent tracheal papillomas, and has since required 2 additional surgical interventions, and now is diagnosed with metastatic SCC lung cancer.

DISCUSSION: RRP can be very resistant to medical and surgical treatment. This patient was refractory to medical treatment that included interferon and intralesional cidofovir. Response to Bleomycin has been reported, and was part of this patient’s Hodgkin’s disease chemotherapy, and may have been associated with slower growth during the treatment period. Mechanical debulking with surgical excision, microdebridement and C02 laser provide temporary benefit. Endobronchial stents are sometimes needed. A small percentage of patients demonstrate malignant transformation to SCC. HPV 11 and smoking are reported risk factors for this. Subtype data was not available for this patient. The HPV vaccine which targets HPV 11 offers hope in reducing the incidence of this frequently complicated disease.

CONCLUSIONS: RRP from HPV infection can be refractory to treatment and may cause upper airway obstruction. Recurrence is expected, and malignant transformation may occur, especially in immunocompromised individuals.

Reference #1: Boston, Mark et al. "Recurrent Respiratory Papillomatosis." Clinical Pulmonary Medicine 10.1 (2003): 10-16.

Reference #2: Chaturvedi, A. K., et al. "Risk of Human Papillomavirus-Associated Cancers Among Persons With AIDS." JNCI 101.16 (2009): 1120-130.

Reference #3: Yuan, Hang, et al. "Use of Reprogrammed Cells to Identify Therapy for Respiratory Papillomatosis." NEJM 367 (2012): 1220-227.

DISCLOSURE: The following authors have nothing to disclose: Rishi Mehta, Jean Anderson Eloy, Andrew Berman

No Product/Research Disclosure Information


Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543